Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

John Thompson has worked on the following 9 EPO patent applications which have been published in the last five years:

EP11720777

ANTIVIRAL ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES

IPC classification:
A61K 31/519, A61K 31/52, A61K 31/551, A61P 31/12, A61P 31/14, A61P 31/16, A61P 31/18
Applicant:
Katholieke Universiteit Leuven
Agent:
John Thompson, UCB Celltech
Status:
EXAMINATION IN PROGRESS
EP11779451

PROCESS FOR PREPARING LACOSAMIDE

IPC classification:
C07C 229/22, C07C 233/47, C07C 237/22
Applicant:
UCB Pharma GmbH
Agent:
Frank Dressen, UCB Pharma GmbH
Agent:
John Thompson, UCB Celltech
Status:
GRANT OF PATENT INTENDED
EP12756727

AUTOIMMUNE AND INFLAMMATORY DISORDER THERAPY

IPC classification:
G01N 33/564
Applicant:
Katholieke Universiteit Leuven
Agent:
John Thompson, UCB Celltech
Status:
EXAMINATION IN PROGRESS
EP12801466

THERAPEUTICALLY ACTIVE THIAZOLO-PYRIMIDINE DERIVATIVES

IPC classification:
A61K 31/519, A61P 29/00, A61P 31/00, A61P 35/00, A61P 37/00, C07D 513/04
Applicant:
Katholieke Universiteit Leuven
Applicant:
UCB Pharma S.A.
Applicant:
UCB Biopharma SPRL
Agent:
John Thompson, UCB Celltech
Status:
PATENT GRANTED
EP13776992

THERAPEUTICALLY ACTIVE OXAZOLINE DERIVATIVES

IPC classification:
A61K 31/519, A61P 29/00, C07D 495/04
Applicant:
Katholieke Universiteit Leuven
Applicant:
UCB Biopharma SPRL
Agent:
John Thompson, UCB Celltech
Status:
EXAMINATION IN PROGRESS
EP15162142

Purine analogues and their use as immunosuppressive agents

IPC classification:
A61K 31/519, A61P 29/00, C07D 513/04
Applicant:
Katholieke Universiteit Leuven
Agent:
John Thompson, UCB Celltech
Status:
EXAMINATION IN PROGRESS
EP13814962

THERAPEUTICALLY ACTIVE PYRAZOLO-PYRIMIDINE DERIVATIVES

IPC classification:
A61K 31/519, A61P 35/00, C07D 487/04
Applicant:
Katholieke Universiteit Leuven
Applicant:
UCB Biopharma SPRL
Agent:
John Thompson, UCB Celltech
Status:
GRANT OF PATENT INTENDED
EP11755423

QUINOLINE AND QUINOXALINE DERIVATIVES AS KINASE INHIBITORS

IPC classification:
A61K 31/519, A61P 9/00, A61P 25/28, A61P 29/00, C07D 471/04
Applicant:
UCB Pharma S.A.
Applicant:
UCB Biopharma SPRL
Agent:
John Thompson, UCB Celltech
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11769929

ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES

IPC classification:
A61K 31/505
Applicant:
Katholieke Universiteit Leuven
Agent:
John Thompson, UCB Celltech
Status:
PATENT GRANTED

Please Sign in to use this feature